Showing 24 out of 58 results
Digital forensics in investigations and the growing data burden
Businesses will need smarter data collection and management strategies to satisfy regulators The approach to digital forensics in investigations is …
Using big data to fight financial crime
In a regulatory environment which demands ever higher standards for anti-money laundering (AML) compliance, many financial institutions have responded by …
Regulators lead businesses in monitoring of misconduct
As regulators and law enforcement increasingly rely on advanced data analytics for monitoring and surveillance, the risk is growing that they will detect …
Big data and Modern Slavery – Progress not panacea
Data analysis can only get you so far in modern slavery compliance… and regulators are watchingWhile the benefits of data and technology can be leveraged …
CJEU rules that providing free samples of non-prescription drugs to pharmacists is permitted
On 11 June, the Court of Justice of the European Union ("CJEU") ruled on the question of whether free samples to pharmacists of medicines may be supplied …
Herbert Smith Freehills advises Achilles Vaccines in record seed financing for biotech sector
Herbert Smith Freehills has advised Achilles Vaccines, a biotech company focusing on the research and development of vaccines against malaria and other …
Patent and Pharma Update, May 2020
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector In this update we welcome our new IP partner …
COVID-19: ÁREAS DE IMPACTO: Últimas novedades en el sector farmacéutico y salud (España)
Detallamos a continuación las últimas órdenes en relación con la gestión de la crisis de la COVID-19 en materia del sector farmacéutico y …
Exploring Opportunities: The impact of Covid-19 on competition law in the pharmaceutical sector (Europe)
The global Covid-19 pandemic has, to an extent, re-directed some of the actions and focus of competition authorities, which are placing increasing …
Patent and Pharma Update, February 2020
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector In this issue we report on the Supreme Court …
ECJ rules for the first time on “pay-for-delay” agreements
On 30 January 2020 the European Court of Justice (“ECJ”) clarified for the first time the criteria governing whether so-called “pay-for-delay” agreements …
Leading pharmaceutical lawyer joins Herbert Smith Freehills in Madrid
Herbert Smith Freehills has added to its European pharmaceuticals platform with the hire of leading Spanish lawyer Lourdes Fraguas to the firm's Madrid …
Showing 24 out of 58 results
View more